By Maggie Fick and Jennifer Rigby LONDON (Reuters) -Drugmakers Bharat Biotech and GSK will cut the price of their malaria ...

Bharat Biotech has entered into partnership in 2021 to produce part of the malaria vaccine that has been developed by British ...

Bharat Biotech and GSK plc will significantly reduce the price of their malaria vaccine, Mosquirix, to under $5 per dose by ...

Bharat Biotech International Ltd and GSK plc on Wednesday said they will reduce the price of the world's first malaria ...

Bharat Biotech and GSK will lower the malaria vaccine price to under $5 by 2028. This is due to better processes and more ...

In a recent development, Bharat Biotech and GSK announced a price reduction of $5, which aims to improve access and save ...

Hyderabad: Bharat Biotech will be reducing the price of world's first malaria vaccine RTS.S, developed by GSK, PATH and ...

When combined with seasonal malaria chemoprevention, the vaccine RTS,S has shown up to 75 per cent efficacy in preventing ...

Bharat Biotech and GSK have announced plans to reduce the price of their malaria vaccine, Mosquirix, to $5 per dose by 2028.

GSK and Bharat Biotech collaborate to reduce malaria vaccine price, enhance production, and supply to Gavi by 2028.

Bharat Biotech and GSK to reduce RTS,S malaria vaccine price to under $5 per dose by 2028, enhancing access for children in ...

As part of a multi-year collaboration, GSK and India’s Bharat Biotech are redoubling their efforts to bring the world’s first malaria vaccine to more countries in need at affordable prices. | The ...